Status:
COMPLETED
Neural Mechanisms of Successful Intervention in Children With Dyslexia
Lead Sponsor:
Stanford University
Collaborating Sponsors:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions:
Dyslexia, Developmental
Eligibility:
All Genders
8-12 years
Phase:
NA
Brief Summary
Dyslexia, an impairment in accurate or fluent word recognition, is the most common learning disability affecting roughly ten percent of children. This proposal capitalizes on cutting edge neuroimaging...
Eligibility Criteria
Inclusion
- Reading difficulties defined as low scores on standardized measures of reading skills
Exclusion
- no major contraindication for MRI (braces, metal implants, pacemakers, vascular stents, or metallic ear tubes).
- Because the study involves measurements of reading and language ability, new recruits will be native English speakers.
- Subjects have no history of neurological disorder, significant psychiatric problems
- exclude claustrophobic subjects since an MRI might be uncomfortable for them.
Key Trial Info
Start Date :
May 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2024
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04323488
Start Date
May 1 2021
End Date
September 1 2024
Last Update
November 14 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford University
Stanford, California, United States, 94305